Managed Care Consensus Recommendations to Facilitate Equitable Access and Optimal Outcomes for Retinal Diseases

Webinar Recorded on July 10, 2024                                    Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

Retinal diseases result in remarkable morbidity among plan members, including vision loss and blindness. Furthermore, disparities exist in incidence and outcomes among those affected by social determinants of health (SDOH). This webcast, presented by, will educate managed care and payer professionals regarding best practices in enhancing retinal disease care equity and access.

Learning Objectives

  • Identify current disparities in the care of retinal diseases.
  • Outline the importance of anti-VEGF therapies with extended duration of effect for patients impacted by SDOH.
  • Describe means by which to address the impact of SDOH via utilization management programs.

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP. This program is provided by Impact Education, LLC and is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.

Sponsored by:

For individuals from the media/press interested in attending, please email

Course summary
Course opens: 
Course expires: 


Mark Barakat, MD
Retina Macula Institute of Arizona

Justin Weiss, PharmD, MBA
VP, Pharmacy Operations & Compliance
Cambia Health Solutions


Please login or register to take this course.